Tirzepatide

Tirzepatide is a dual GIP and GLP-1 receptor agonist, representing the active peptide backbone found in Mounjaro®. It’s a next-generation incretin analog studied for its effects on insulin sensitivity, lipid metabolism, and appetite regulation. Tirzepatide offers a dual-mechanism model for exploring energy balance, glucose control, and metabolic flexibility through combined receptor signaling.